Fund Holdings — Lynx1 Capital Management LP

Total Portfolio Value
$388.25M
Total Bought
$124.61M
Total Sold
$36.03M
Net Transaction
+$88.59M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
MERUS N V1,135,2251,509,007+373,78231,21967,95117.50%+36,732
STOKE THERAPEUTICS INC(STOK)2,956,9183,696,820+739,90215,55349,90712.85%+34,354
GH RESEARCH PLC(GHRS)1,838,6173,310,563+1,471,94610,66435,2919.09%+24,627
ALPINE IMMUNE SCIENCES INC3,813,9262,253,183-1,560,74372,69389,31623.00%+16,623
C4 THERAPEUTICS INC(CCCC)3,134,3963,634,662+500,26617,70929,6957.65%+11,986
TSCAN THERAPEUTICS INC(TCRX)5,224,6005,224,600030,45941,48310.68%+11,024
SILENCE THERAPEUTICS PLC(SLN)235,787526,642+290,8554,09611,3752.93%+7,280
PASSAGE BIO INC(PASG)379,1594,845,871+4,466,7123836,5421.68%+6,159
IBIO(IBIO)0600,000+600,00002,4360.63%+2,436
NEKTAR THERAPEUTICS(NKTR)1,929,1982,068,842+139,6441,0901,9330.50%+843
KINNATE BIOPHARMA INC1,997,0061,981,106-15,9004,7335,2701.36%+537
CENTESSA PHARMACEUTICALS PLC017,400+17,40001970.05%+197
PIERIS PHARMACEUTICALS INC9,775,8498,779,162-996,6871,7791,6080.41%-171
BIONOMICS LIMITED824,305814,467-9,8381,2208390.22%-381
THESEUS PHARMACEUTICALS INC702,4150-702,4152,8450—-2,845
AUTOLUS THERAPEUTICS PLC(AUTL)1,858,4091,390,160-468,24911,9688,8692.28%-3,099
CABALETTA BIO INC(CABA)2,110,4012,082,973-27,42847,90635,5369.15%-12,371
Page 1 of 1
Lynx1 Capital Management LP — 13F Holdings — Q1 2024 | TickerTrail